Is Compass Therapeutics Inc. halal to invest in?

According to Musaffa's Shariah screening methodology, Compass Therapeutics Inc. (CMPX) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Compass Therapeutics Inc. a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Compass Therapeutics Inc. using these criteria to determine its compliance status.

Can Muslims buy shares of Compass Therapeutics Inc.?

Muslim investors may consider investing in Compass Therapeutics Inc. if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Compass Therapeutics Inc. classified as NOT HALAL?

Musaffa determines the Shariah status of Compass Therapeutics Inc. by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Compass Therapeutics Inc. updated?

The Shariah compliance status of Compass Therapeutics Inc. may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Compass Therapeutics Inc. become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Compass Therapeutics Inc.?

You can check the latest Shariah compliance status of Compass Therapeutics Inc. on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

CMPX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 10, 2026

Report Source: 2025 Annual Report

Compass Therapeutics Inc.. Stock Analysis CMPX

United States Health Care Small Cap Report: 2025 Annual

The company is headquartered in Boston, Massachusetts and currently employs 39 full-time employees. The company went IPO on 2020-11-13.

Key Statistics of Compass Therapeutics Inc. (CMPX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$1.85$1.96

Today's Open

$1.93

Volume

3.87M

P/E Ratio (TTM)

52 Week Range

$1.61$6.88

Market Cap

351.17M

Avg. Volume

15.06M

Dividend Yield

Financial Metrics & Statements of Compass Therapeutics Inc. (CMPX)

FAQ's for Compass Therapeutics Inc. (CMPX)

According to Musaffa’s Shariah screening methodology, Compass Therapeutics Inc. (CMPX) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.